Order Article Reprints

Kim E-J, Kang J-I, Kwak J-W, Jeon C-H, Tung N-H, Kim Y-H, Choi C-H, Hyun J-W, Koh Y-S, Yoo E-S, et al. The Anticancer Effect of (1S,2S,3E,7E,11E)-3,7,11, 15-Cembratetraen-17,2-olide(LS-1) through the Activation of TGF-β Signaling in SNU-C5/5-FU, Fluorouracil-Resistant Human Colon Cancer Cells. Marine Drugs. 2015; 13(3):1340-1359. https://doi.org/10.3390/md13031340

Kim, Eun-Ji, Jung-Il Kang, Jeon-Won Kwak, Chan-Hee Jeon, Nguyen-Huu Tung, Young-Ho Kim, Cheol-Hee Choi, Jin-Won Hyun, Young-Sang Koh, Eun-Sook Yoo, and et al. 2015. "The Anticancer Effect of (1S,2S,3E,7E,11E)-3,7,11, 15-Cembratetraen-17,2-olide(LS-1) through the Activation of TGF-β Signaling in SNU-C5/5-FU, Fluorouracil-Resistant Human Colon Cancer Cells" Marine Drugs 13, no. 3: 1340-1359. https://doi.org/10.3390/md13031340

Kim, E.-J., Kang, J.-I., Kwak, J.-W., Jeon, C.-H., Tung, N.-H., Kim, Y.-H., Choi, C.-H., Hyun, J.-W., Koh, Y.-S., Yoo, E.-S., & Kang, H.-K. (2015). The Anticancer Effect of (1S,2S,3E,7E,11E)-3,7,11, 15-Cembratetraen-17,2-olide(LS-1) through the Activation of TGF-β Signaling in SNU-C5/5-FU, Fluorouracil-Resistant Human Colon Cancer Cells. Marine Drugs, 13(3), 1340-1359. https://doi.org/10.3390/md13031340